CMT Solutions will simplify and streamline the patient access services including prior authorization for laboratory diagnostic testing, through our proprietary technological solution. We have a dedicated team of specialists that will work on behalf of the physician and the laboratory to reduce barriers, and help patients gain access to their laboratory diagnostic testing.

A conference dedicated to innovative companies that are launching high value diagnostic tests into the U.S. market. Conference is held twice a year: March (east coast) September (west coast) to discuss best practices for commercial launches into the personalized medicine/companion diagnostics arena. The conference covers Coding, Coverage, Regulatory, Clinical Trial Formation, and Payor Relations activities.Join us for our next conference April 2nd in Boston

At AccessDx our goal is to help patients receive personalized medicine by making it easier for patients to access personalized medicine tests (PMDx). It is our core belief that there is no personalized medicine without the direct involvement of a PMDx to help direct care. We want to bridge the gap by having a network of interested allies (patients, patient advocacy groups, physicians, payors, and PMDX companies) working together to deliver personalized medicine.Our network called the AccessDx Alliance is the platform for observational/registry trials to take place with the goal of:validating the personalized medicine diagnostic tests (PMDx) in a real world setting (majority of cancer care is performed by the community oncologists not at the major academic centers. Yet most trials take place at these academic centers) collecting clinical utility data to demonstrate better patient outcomes. (Making sense of big data)integrating the PMDx tests that have "passed the test" into standard care. (combining clinical outcomes and patient reported data to represent true value)providing payors a standardized pathway for medical policy adoptionThere are many networks that have been developed to perform clinical trials for drug therapies. However, there are no networks exclusively devoted to validate PMDx tests. AccessDx is the devoted network for PMDx tests.

Leading the Premier Source team as we provide strategic reimbursement consulting and billing services to laboratory developed testing (LDT) companies who are launching novel diagnostic tests in the US.Provide tactical solutions to reimbursement challenges for high value diagnostic tests

Strategic consulting to laboratory diagnostic companies.Provide tactical solutions to reimbursement challenges for high value diagnostic tests

Led all aspects of reimbursement and managed care activities for the Precision's ChemoFx drug response marker.I also worked for Precision from September 2001- May 2004 as the Director of Managed Care.

Led the Reimbursement team responsible for bringing the value based diagnostic test, AlloMap molecular expression testing, to market. This included all aspects of reimbursement, Coverage, Coding, Payment,Contracting and Payor Relations activities.Created appeals management team to coordinate with billing.

Part of a team that successfully secured universal coverage for the company's new cervical cancer screening product, the ThinPrep Pap Test.